Medicine & Life Sciences
Alzheimer Disease
100%
Amyloid
63%
Cognitive Dysfunction
49%
Dementia
41%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
40%
White Matter
35%
Biomarkers
31%
Atrophy
31%
Brain
30%
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole
26%
Positron-Emission Tomography
25%
Pathology
24%
Neuroimaging
22%
Frontotemporal Lobar Degeneration
21%
Frontotemporal Dementia
20%
Cognition
19%
Magnetic Resonance Imaging
17%
Gray Matter
16%
Creatine
16%
Temporal Lobe
14%
N-acetylaspartate
13%
Diffusion Tensor Imaging
12%
Mutation
11%
Neurofibrillary Tangles
11%
REM Sleep Behavior Disorder
10%
Gyrus Cinguli
10%
Autopsy
10%
Inositol
9%
Deep Learning
9%
Proton Magnetic Resonance Spectroscopy
8%
Hormones
8%
Infarction
8%
Disease Progression
7%
Microtubule-Associated Proteins
7%
Population
7%
Cerebral Amyloid Angiopathy
6%
Fluorodeoxyglucose F18
6%
Elderly
6%
Lewy Bodies
6%
Protons
6%
Anisotropy
6%
Neuropathology
6%
Memory
6%
Parietal Lobe
6%
Phenotype
6%
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
6%
Clinical Trials
5%
Mental Status and Dementia Tests
5%